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Endocarditis pathogens colonize valves with pre-exist-
ing sterile vegetations or valves with minimal endothelial 
lesions. Inﬂamed endothelia produce cytokines, integ-
rins, and tissue factor, which in turn attract ﬁbronectin, 
monocytes, and platelets. Bacteria attaching to such 
structures further activate the cascade, becoming embed-
ded and protected from host defenses. Staphylococcus 
aureus also actively invade the endothelium, causing 
apoptosis and endothelial damage. Knowledge of this 
interplay identiﬁes host factors as potential therapeutic 
targets. Blocking infection by modulating host factors 
might be opportune because host factors are conserved. 
In contrast, interfering with bacterial virulence factors 
might be more complicated because they vary among 
different bacteria.
Introduction
Despite improvements in health care, the incidence 
of infective endocarditis (IE) (2–6 per 100,000 pop-
ulation per year) has not changed over the past two 
decades [1,2]. This apparent paradox results from 
progressive modifications in risk factors. Chronic 
rheumatic heart disease is now rare in industrial-
ized countries. This group of at-risk patients has 
been replaced with new at-risk patients, including 
intravenous drug users, elderly people with valve scle-
rosis, patients with intravascular prostheses, patients 
exposed to nosocomial bacteremia, and hemodialysis 
patients [1–3]. As a result, the mean age of patients 
with IE has increased from 30 years in the 1950s to 
older than 60 years since the 1990s. IE involves both 
host and microbial factors. The principal actors of this 
liaison dangereuse are reviewed.
The Critical Role of Host Factors
The valve endothelium
The normal valve endothelium is very resistant to infec-
tion. However, mechanical lesions of this endothelium 
result in exposure of the underlying extracellular matrix 
proteins, local inﬂammation, and deposition of ﬁbrin and 
platelets, which form a nonbacterial thrombotic endo-
carditis (NBTE) that is prone to bacterial colonization. 
Congenital cardiac abnormalities cause turbulent blood 
ﬂow, which may provoke endothelial trauma. Valve scar-
ring and calciﬁcation related to rheumatic carditis or valve 
sclerosis in elderly patients result in endothelial lesions. 
Degenerative valve lesions are detected in up to 50% of 
patients older than 60 years of age and may explain the 
increased risk for IE in the elderly [4]. Extrinsic interven-
tion, such as prosthetic valve replacement or indwelling 
electrodes or catheters, also promotes endothelial lesions. 
In addition, Chlamydia pneumoniae or cytomegalovirus has 
been linked to atherosclerosis. Whether these conditions 
trigger endothelial lesions that promote IE is not known. 
IE may also occur without identiﬁable pre-existing 
valve lesions. This is particularly true for Staphylococ-
cus aureus, which has emerged as the leading cause of 
IE in recent surveys [1,2]. Local inﬂammation, which 
may occur in some circumstances, triggers endothelial 
cells to express a variety of molecules, including inte-
grins of the β1 family (very late antigen). Integrins are 
transmembrane proteins that can connect extracellular 
determinants to the cellular cytoskeleton. Integrins of 
the β1 family bind circulating ﬁbronectin to the endothe-
lial surface. S. aureus and a few other IE pathogens carry 
ﬁbronectin-binding proteins anchored to their walls. 
Thus, ﬁbronectin bound by activated endothelia provides 
an adhesive surface to these circulating bacteria. 
Inﬂammation and coagulation 
Inﬂammation and coagulation are very closely related. 
Tissue factor (TF), which is a main player in coagulation 
and vegetation growth, is induced from monocytes and 
endothelial cells by interleukin (IL)-1 [5], which is itself 
produced in response to tissue injury. In turn, endothelial 
cells and monocytes produce proinﬂammatory cytokines 
and integrins that favor the construction of the NBTE 
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and thus the attachment of circulating bacteria. Once 
attached, microbes further maintain this vicious cycle 
that promotes growth of the vegetation, in which they 
are protected from host defenses. A synthetic view of this 
complex cycle is starting to emerge. However, although 
microbial characteristics may change according to the 
infecting species, the host counterparts are conserved. 
Therefore, critical host components could be convenient 
targets for adjuvant interventions to antibiotherapy. 
Tissue factor
TF is a procoagulant integral membrane glycoprotein 
of 47 kD. It is produced on the surface of virtually all 
cells except for unperturbed endothelia and circulating 
blood cells [5]. When endothelial damage occurs, TF 
from underlying tissues reacts with factor VII and factor 
X, which cleave prothrombin to thrombin, which trig-
gers the polymerization of ﬁbrinogen into ﬁbrin. TF also 
activates platelets, which are integral components of the 
vegetation [6]. Although unperturbed endothelia and 
monocytes do not produce TF, they can be induced to 
produce it by various agonists, including cytokines (IL-
1) and bacterial products [5]. Intravegetation TF activity 
(TFA) was demonstrated in specimens from experimental 
IE due to Streptococcus sanguis, S. aureus, and Staphylococcus 
epidermidis, and the presence of TFA was associated with 
the presence of the microbes [7,8]. 
Induction of TFA from the host monocytes
Monocytes are present in the early vegetation, and their 
binding to ﬁbrin clots elicits TFA in vitro [9]. More-
over, addition of S. sanguis to the system increases TFA 
approximately 10-fold. This occurred in spite of the fact 
that monocytes could not physically engulf and remove 
ﬁbrin-adherent streptococci—a phenomenon referred 
to as “frustrated phagocytosis”—suggesting that some 
extrinsic bacterial factor was involved. Such microbial 
factors interacting with innate host defenses have been 
referred to as modulins. S. aureus and S. epidermidis can 
also induce TFA from monocytes [7,8]. Moreover, the 
contribution of monocytes to intravegetation TFA was 
conﬁrmed in animals with etoposide-induced monocy-
topenia [7,8]. Thus, bacteria can encourage vegetation 
growth by subverting monocytes to produce TFA. 
Induction of TFA from the host endothelium
Because S. aureus IE might develop on physically intact 
endothelia, the question arose as to whether these organ-
isms can trigger local vegetation formation by direct 
induction of endothelial TFA. Veltrop et al. [7] showed that 
S. aureus, but not S. epidermidis and S. sanguis, could induce 
TFA expression from cultured endothelial cells. Treating 
these cells with IL-1 also induced TFA. However, abrogat-
ing the IL-1 response with IL-1-receptor antagonist did 
not abrogate TFA induction by S. aureus. Thus, IL-1 and S. 
aureus induce endothelial TFA by distinct mechanisms. 
Induction of endothelial TFA with S. epidermidis and 
S. sanguis needed the additional presence of monocytes 
[10]. This required endothelial expression of intercel-
lular adhesion molecule 1 (ICAM-1) and vascular cell 
adhesion molecule 1 (VCAM-1), which depend on pre-
existing endothelial activation. Therefore, although S. 
aureus and IL-1 might be enough to initiate endothelial 
procoagulant activity, S. epidermidis and S. sanguis depend 
on a pre-existing endothelial stress (or damage) to trigger 
the same effect. 
Cytokines
Recently, Dankert et al. [11••] highlighted the role of 
IL-1α in maintaining endothelial inﬂammation. In 
experimental endocarditis, the initial valve lesion is pro-
duced via a catheter inserted through the valve leaﬂets 
and left in place throughout the experiment. Bacteria 
injected thereafter infect the damaged valves. The authors 
observed that removal of the catheter 24 hours before 
bacterial challenge was enough to restore resistance to 
infection, presumably due to spontaneous endothelial 
repair. However, animals from which the catheter had 
been removed could be rendered susceptible to infec-
tion again by injection of IL-1α 3 hours prior to bacterial 
challenge. This 3-hour window corresponded to the time 
required for IL-1 to induce maximal TFA from endothe-
lial cells in vitro. Thus, IL-1α could resensitize endothelia 
with minimal lesions to infection susceptibility. Systemic 
inﬂammation could be important in moderate valve 
anomalies as in early degenerative lesions, or following 
illicit drug injection where impurities are thought to 
produce minimal lesions to the leaﬂets’ endothelium. 
Concurrent inﬂammation due to unrelated diseases could 
increase susceptibility to IE in these conditions. It would 
be important to know whether IL-1α has the same effect 
on nonprimed endothelia, but this is as yet uncertain.
The platelets paradox
Bacterial-induced platelet aggregation is commonly con-
sidered to be a pathogenic factor. However, platelets also 
contribute to anti-infective host defenses by releasing 
antimicrobial peptides and inﬂammatory mediators [6]. 
Platelets harbor three types of granules (α, δ, and λ), which 
release a variety of mediators involved in adhesion and 
coagulation (α granules), vascular tone (δ granules), and 
thrombus dissociation (λ granules) [6]. α Granules also 
contain an arsenal of antimicrobial peptides, collectively 
called platelet microbicidal proteins (PMPs), in rabbit plate-
lets and thrombocidins in human platelets. PMPs represent 
one of the ﬁrst host-defense barriers in IE, and are released 
upon platelet stimulation, for instance by thrombin.
Pathogenic role in streptococcal IE
S. sanguis has the ability to induce platelet aggregation 
via two surface-expressed antigens [12]. The class I anti-
gen promotes streptococcal adhesion to platelets (Adh+ 
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phenotype). The class II antigen triggers further platelet 
aggregation (Agg+ phenotype). This so-called platelet 
aggregation-associated protein contains a collagen-like 
platelet-interacting domain [12]. Studies indicated that 
an Agg+ isolate of S. sanguis produced more severe infec-
tion and larger vegetations than an Agg– control strain in 
experimental IE [13]. However, other studies did not ﬁnd 
such a correlation. In these studies the Agg– comparator 
strains were not characterized for other pro-endocarditis 
factors, or were less adherent to ﬁbronectin, ﬁbrinogen, 
and platelet-ﬁbrin clots [13]. Moreover, not all IE strepto-
coccal isolates are Agg+, indicating that additional factors 
are involved [14].
Streptococcal-platelet binding was further character-
ized in Streptococcus mitis [15]. Binding was mediated 
by a complex interaction between at least three loci, 
pblA, pblB, and pblT. PblA and PblB are surface structures 
that are likely to act as adhesins. They are encoded by a 
lysogenic bacteriophage (SM1) of S. mitis, suggesting 
that they might disseminate to other pathogens. PblT 
is homologous to a membrane transporter of the major 
facilitator superfamily. Solute-binding proteins of such 
transport systems have been shown to mediate adher-
ence. However, mutants in these loci have not been tested 
in experimental IE. 
Pathogenic role in staphylococcal IE
S. aureus organisms bind platelets directly or indirectly 
via several surface proteins, including ﬁbrinogen-bind-
ing and ﬁbronectin-binding proteins, as well as a newly 
described serine-rich protein called SraP (Table 1) [16–
19]. Adhesion of S. aureus to activated platelets may also 
occur via thrombospondin, von Willebrand factor, pro-
tein A, and/or C1q bridging.
Table 1. Potential Staphylococcus aureus MSCRAMMs belonging to the LPXTG-anchoring domain 
family of wall-associated proteins 
Gene Protein Function Potential implication in disease
spa Protein A Binds antibody Fc fragment Experimental sepsis
Experimental osteoarthritis
clfA Clumping factor A Binding to ﬁbrinogen and platelets Experimental endocarditis
clfB Clumping factor B Binding to ﬁbrinogen Not proven in endocarditis
cna Collagen-binding protein Binding to collagen Experimental arthritis
fnbA Fibronectin-binding protein A Binding to ﬁbronectin,  
ﬁbrinogen, elastin
Experimental endocarditis
Activates platelets Cell invasion
fnbB Fibronectin-binding protein B Binding to ﬁbronectin and ﬁbrinogen Undetermined
Activates platelets
sdrC Serine-aspartate repeat protein Binding to ﬁbrinogen Undetermined
sdrD Serine-aspartate repeat protein Possible binding to ﬁbrinogen Undetermined
sdrE Serine-aspartate repeat protein Possible binding to ﬁbrinogen Undetermined
pls Plasmin-sensitive protein Binding to nasal mucosal cells Colonization of nasal mucosa
fmtB Factor affecting methicillin resistance 
in the presence of Triton X-100
Putative cell-wall building Affects the expression of  
methicillin resistance
sasA (sraP) S. aureus surface protein A Platelet binding Possible in experimental endocarditis
sasB S. aureus surface protein B Undetermined Undetermined
sasC S. aureus surface protein C Undetermined Undetermined
sasE S. aureus surface protein E Implicated in transferring binding Undetermined
sasF S. aureus surface protein F Undetermined Undetermined
sasG S. aureus surface protein G Binding to nasal mucosal cells Associated with invasive disease
sasH S. aureus surface protein H Undetermined Associated with invasive disease
sasI S. aureus surface protein I Undetermined Undetermined
sasJ S. aureus surface protein J Implicated in transferring binding Undetermined
sasK S. aureus surface protein K Undetermined Undetermined
MSCRAMMs—microbial surface component reacting with adhesive matrix molecules. 
(Adapted from Siboo et al. [18], Que et al. [40••], and Roche et al. [44].)
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Sullam et al. [20] compared an Agg+ parent S. aureus 
to a Tn551-insertional mutant with decreased platelet-
binding and aggregation in experimental endocarditis. 
The parent strain was up to 100-fold more infective 
than the mutant, as determined 48 hours after chal-
lenge. The organisms were comparable for other relevant 
virulence properties, including their susceptibility to 
platelet peptide-induced killing, and their ability to 
bind to ﬁbrinogen and ﬁbronectin. This provides strong 
evidence for the implication of S. aureus–induced plate-
let aggregation in IE pathogenesis. The same laboratory 
showed that ﬁbrinogen-binding protein A (ClfA) was 
involved in this interaction.
The antimicrobial effects of platelets
Conversely, experimental IE due to an S. sanguis strain 
was more severe in thrombocytopenic rabbits than in 
control animals with normal platelet counts [21]. The 
infecting organism extensively aggregated platelets, but 
was rapidly killed by PMPs in vitro. Dankert et al. [22] 
conﬁrmed the role of PMPs in experimental IE by using 
a series of PMP-susceptible and PMP-resistant streptococ-
cal isolates. PMP-susceptible streptococci colonized more 
effectively damaged valves than PMP-resistant strains 5 
minutes after bacterial challenge. However, they were rap-
idly eradicated from the vegetations during the following 
24 to 48 hours, whereas PMP-resistant strains persisted. 
Therefore, although bacteria may subvert platelets to 
develop the vegetation, they need to resist PMP-induced 
killing to take advantage of this procoagulant effect.
The mechanism of action of PMP was clariﬁed in S. 
aureus. Thrombin-induced PMP-1 (tPMP-1), the principal 
PMP released from rabbit platelets, is a cationic molecule 
of relatively small size (8.036 Da). It permeabilizes the 
cytoplasmic membrane in a voltage-dependent manner 
without classic pore formation [23], which is different 
from other types of bactericidal peptides. Recently, resis-
tance to PMP-induced killing was associated with the 
dltABC and mrpF loci, the products that are responsible 
for alanylation of surface teichoic and lipoteichoic acids, 
and lysinylation of membrane phosphatidyl glycerol [24]. 
Both of these surface structures are positively charged. 
They are likely to repel the cationic PMPs and, thus, pro-
tect the bacterium. 
Clinical implication of PMPs
Experimental studies support the protective role of PMPs 
in intravascular infections [21,22]. In humans, S. aureus 
isolates from intravascular infections were more often 
resistant to PMPs than those isolated from other types 
of infections [25]. PMPs may also play a role in therapy. 
tPMP-1 acted synergistically with several antibiotics—in 
particular, cell-wall active drugs—both in vitro and in 
vivo [14], and the effect was observed against both PMP-
susceptible and PMP-resistant isolates. Thus, development 
of PMP analogues for therapy may be envisioned.
 Because platelets are involved in IE, investigators 
explored the effect of adjuvant antiplatelet therapy in the 
disease. Limited clinical observations suggest that aspirin 
might prevent vegetation growth and decrease cerebral 
septic emboli in human IE [26]. Nicolau et al. [27] studied 
the effect of aspirin and ticlopidine, two antiplatelet drugs 
with different modes of action, in rabbits with S. aureus 
experimental IE. Both drugs synergistically decreased the 
vegetation size, and also moderately decreased vegetation 
bacterial titers. However, the PMP-resistance phenotype 
of the infecting organism was not reported. 
Aspirin also signiﬁcantly decreased vegetation weight, 
vegetation bacterial titers, and renal septic emboli in S. 
aureus experimental IE [28]. In these experiments, pre-
exposure of platelets to aspirin and preexposure of S. 
aureus to salicylic acid (the principal metabolite of aspirin 
in vivo) decreased platelet adherence and aggregation as 
well as bacterial adherence to ﬁbrin and ﬁbrin-platelet 
matrices in vitro. One reason is that salicylic acid can 
block the expression of global regulator agr, thus altering 
the expression of S. aureus pathogenic factors [28]. Thus, 
aspirin acts both on the platelets and on the microbe. 
Experiments also indicated that aspirin, but not ticlopi-
dine, was synergistic with vancomycin in increasing valve 
sterilization during experimental therapy. Whether this is 
also true for streptococci is as yet not determined. How-
ever, although platelet antiaggregants have a potential 
efﬁcacy, extrapolating these experimental results to the 
human situation must be tempered by the risk of hemor-
rhage related to anticoagulation during acute IE [29].
The role of transient bacteremia
Medicosurgical procedures in nonsterile anatomic sites 
may provoke transient bacteremia. However, mastication 
and tooth brushing do so as well [30,31]. The duration 
of bacteremia after dental manipulation is short (≤ 15 
minutes), and its magnitude is not very different during 
various dental procedures compared to normal activity 
[31]. It was reported to be 1 to 10 colony-forming units 
(CFU)/mL versus 10 CFU/mL during mastication and 
dental extraction, respectively [30]. It was estimated that 
the cumulative numbers of circulating bacteria (in CFU/
mL/y) resulting from 1) mastication, 2) tooth brush-
ing two times per day, and 3) dental examination were 
5.6 million times, 154,000 times, and 48 times greater, 
respectively, than that provoked by a single tooth extrac-
tion [32]. This probably explains why most cases of IE are 
not preceded by medicosurgical procedures. Moreover, 
if the cumulative exposure to circulating bacteria is a 
greater risk factor for IE than the magnitude of bactere-
mia during dental procedures, then the recommendation 
for antibiotic prophylaxis should be revisited. This issue 
remains to be solved.
Besides bacteremia of dental origin, two increasingly 
frequent “health care–associated” bacteremia are of con-
cern: bacteremia in hemodialysis patients and nosocomial 
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bacteremia. IE is up to three times more frequent in hemo-
dialysis patients than in the general population [3] and 
more than 50% of the cases are due to S. aureus. Nosoco-
mial IE accounted for 22% of 109 cases in one study [2]. 
Many patients had debilitating conditions, but less than 
50% had known cardiac predisposing factors. The pre-
dominant pathogens were staphylococci and enterococci, 
which were frequently associated with catheters and/or 
medicosurgical procedures, and mortality was more than 
50% [2]. It was estimated that more than 10% of nosoco-
mial S. aureus bacteremia was responsible for subsequent 
IE. Therefore, these new conditions are important.
Microbial Factors
S. aureus, Streptococcus spp., and enterococci are respon-
sible for more than 80% of all IE cases [1,2]. These 
organisms possess surface adhesins that mediate attach-
ment to the vegetation and may modulate inﬂammation. 
These adhesins are collectively referred to as MSCRAMMs 
(microbial surface component reacting with adhesive 
matrix molecules) [33].
MSCRAMMs of viridans streptococci
Some streptococcal MSCRAMMs that were studied in 
experimental IE were reviewed [14]. Glucans are surface 
polysaccharides produced from dietary sucrose by bacte-
rial glucosyltransferase (Gtf) and fructosyltransferase 
(Ftf) enzymes. Glucan production increases strepto-
coccal adherence to damaged valves and ﬁbrin-platelet 
clots, and triggers the production of IL-6 in vitro [34]. 
MSCRAMMs’ role in experimental IE was demonstrated 
by using conditions favoring or not favoring the produc-
tion of these surface polysaccharides, as well as in gtf and 
ftf inactivated mutants of Streptococcus mutans. However, 
gtf inactivation did not decrease experimental infectivity 
in all streptococci, indicating that glucans are not uni-
formly required.
FimA is a pathogenic factor in Streptococcus parasan-
guis. Its inactivation greatly decreased the ability of S. 
parasanguis to adhere to immobilized ﬁbrin, and to cause 
IE in rats. Moreover, immunization of animals with FimA 
conferred protection against subsequent experimental IE 
with the original strain [35]. FimA belongs to a family of 
oral mucosal adhesins, including SsaB of S. sanguis, ScaA 
of Streptococcus gordonii, PsaA of Streptococcus pneumoniae, 
and EfaA of Enterococcus faecalis. FimA-like proteins were 
found by cross-hybridization in a number of streptococci, 
suggesting that immunization could confer cross-protec-
tion against several organisms. Further experiments are 
required to conﬁrm this hypothesis. 
MSCRAMMs of S. aureus
S. aureus is extremely well equipped with both MSCRAMMs 
and secreted factors that mediate tissue colonization and 
invasion. Most described MSCRAMMs (Table 1) are cova-
lently attached to the peptidoglycan via sortase processing 
of LPXTG proteins [36]. Other protein MSCRAMMs are 
loosely attached to the wall, including coagulase, extracel-
lular adherence protein [37], and the recently described 
autolysin Aaa [38]. Nonprotein adhesins that promote 
experimental IE include teichoic acids, which mediate 
binding to platelets and endothelial cells [24,39].
This intricate context makes it difﬁcult to analyze 
the pathogenic role of individual gene products by 
classic gene-inactivation and gene-complementation 
experiments. To circumvent this problem, systems were 
developed to express individual staphylococcal deter-
minants in surrogate bacteria missing the rest of the 
redundant staphylococcal environment. Using a system 
developed in Lactococcus lactis, Que et al. [40••] demon-
strated that S. aureus ClfA was necessary and sufﬁcient for 
early valve colonization and infection in rats with experi-
mental IE, but not sufﬁcient for invasive and persistent 
disease. Lactococci equipped with ClfA had a more than 
100-fold increased ability to colonize damaged valve 
over the control parent. However, they were progressively 
eradicated from the vegetations within 72 hours [40••]. 
This spontaneous healing is not characteristic of IE and 
was most likely due to the susceptibility of L. lactis to 
PMP-induced killing.
In the same study, ﬁbronectin-binding protein A 
(FnBPA) promoted both early valve colonization and 
persistent infection. FnBPA is a peculiar MSCRAMM 
carrying at least three binding speciﬁcities—to ﬁbronec-
tin, to ﬁbrinogen, and to elastin [41–43]. Constructing 
truncated proteins expressing only speciﬁc FnBPA-bind-
ing regions conﬁrmed that ﬁbrinogen binding was 
necessary and sufﬁcient for early valve colonization, as 
observed with ClfA. In addition, ﬁbronectin binding 
was necessary for further invasion and persistence. This 
invasive phenotype was associated with the capacity of 
ﬁbronectin binding to trigger active internalization of 
staphylococci into eukaryotic cells, both in vitro and in 
vivo [40••]. However, truncated FnBPA expressing only 
ﬁbronectin binding was unable to colonize damaged 
valves at ﬁrst, and required the simultaneous expres-
sion of ﬁbrinogen binding to provoke infection [40••]. 
Moreover, cooperation between ﬁbrinogen-binding 
and ﬁbronectin binding could occur both in cis, when 
the two domains were present on the same protein as 
in FnBPA, and in trans, when both ﬁbrinogen-binding 
and ﬁbronectin-binding domains were present on two 
separate surface molecules simultaneously expressed 
by separate plasmids in lactococci [40••]. Thus, inter-
adhesin cooperation might also occur between other 
MSCRAMMs, adding even more ﬂexibility to the already 
wealthy set of S. aureus surface determinants.
Role of other protein-MSCRAMMs in S. aureus IE
S. aureus staphylococci carry up to 21 LPXTG-attached sur-
face proteins, of which 10 have a known adhesin function 
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(Table 1) [44]. In ongoing work (Widmer et al., Unpub-
lished data), we succeeded in cloning and expressing 17 of 
them in the lactococcal system (Fig. 1). Protein expression 
was assessed by mass spectrometry and the recombinant 
lactococci were tested for in vitro adherence and in vivo 
infection in rats with experimental IE (Fig. 1). Adherence 
tests conﬁrmed known properties of ClfA, ClfB, FnBPA, 
FnBPB, and collagen-binding protein (Cna). In addition, 
new properties were detected, such as adherence to ﬁbrino-
gen by plasmin-sensitive protein (Pls), and adherence to 
keratin by ClfA, FnBPA, and Sdr. However, in spite of these 
functional redundancies, only ClfA and FnBPA signiﬁcantly 
(P < 0.05) promoted infection in experimental IE (Fig. 1).
It was surprising that ClfB and FnBPB, which both 
bind ﬁbrinogen, did not promote valve infection. One 
hypothesis is that their ﬁbrinogen-binding sites became 
saturated by soluble ﬁbrinogen in the plasma before bind-
ing to the vegetation [45]. It is also relevant that ClfB did 
not affect experimental IE in S. aureus–deleted mutants. 
Nevertheless, although the contribution of other adhesins 
is not entirely excluded, these results underline the criti-
cal role of ClfA and FnBPA in endovascular infection. 
Role of gene regulation
The expression of surface and secreted factors is orches-
trated by the global regulators agr (accessory gene 
regulator), sar (staphylococcal accessory regulator), and 
other determinants, including sigB [46]. Together, sar 
and agr coordinately regulate the expression of adhesins 
during exponential growth and the secretion of soluble 
factors in the postexponential growth phase in vitro. 
Moreover, they were shown to be critical for infectivity in 
experimental IE and other models in vivo [47,48].
Regulation of adhesions
Inactivating agr alone decreased pathogenicity in experi-
mental-model subcutaneous abscesses, where exoprotein 
production is likely to be important [48]. Nevertheless, 
agr inactivation did not have much inﬂuence on the 
course of experimental endocarditis, where bacterial 
surface adhesins are critical for valve colonization [47]. 
The logic to this result is that agr inhibits adhesin produc-
tion in the late exponential phase, whereas the negative 
mutant does not. Therefore, although the negative mutant 
is hampered in exoprotein production, it is still fully 
equipped with surface-bound colonizing determinants. 
The effect of agr deletion could be partially restored by 
concomitant activation of the reciprocal regulator rot, 
thus highlighting the complexity of the network.
However, inactivating sar decreased infectivity in 
experimental IE because it also decreased the expres-
sion of surface adhesins [47], whereas overexpression of 
Figure 1. Induction of experimental endocarditis with lactococcal recombinants expressing 17 of the 21 LPXTG wall-attached proteins of 
Staphylococcus aureus (Table 1). Groups of 10 rats with catheter-induced aortic vegetations were challenged with 106 colony-forming units 
of each of the recombinant organisms, and the proportion of valve infection was assessed 16 hours later. The test strains are indicated at the 
bottom of each column. pIL253 (asterisk) stands for the control Lactococcus lactis carrying an empty expression vector. The other 17 abbre-
viations represent the name of the staphylococcal protein expressed by each of the tested recombinants. Daggers indicate that the percentage 
of infected vegetations was statistically different from that of the pIL253 control strain (P < 0.05) [47].
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sigmaB increased early infectivity because it increased 
the expression of ﬁbrinogen binding [49]. This further 
underlines the role of ﬁbrinogen binding in IE induction.
Regulation of exoproteins
Regulation of adhesin expression is important because it 
affects colonization. However, regulation of exoproteins 
and toxin expression is critical as well. As mentioned, 
FnBPA-positive lactococci or S. aureus can invade peri-
vegetation endothelial cells after colonization. After 
endothelium invasion, the recombinant lactococci can 
divide, but mostly remained trapped inside the cells. In 
contrast, after internalization, S. aureus can lyse the cells 
and spread further [40••]. 
Cell lysis is mediated by hemolysins, which are posi-
tively regulated by agr [46]. Yet, although hemolysins 
are useful for escaping the host cell, they are danger-
ous when the bacteria become exposed to blood cells. 
Staphylococcal mutants overexpressing α-hemolysin 
produced less severe experimental IE than did parent 
strains, presumably because they lysed and activated 
platelets, which consequently released PMPs [50]—thus, 
the importance of hemolysin regulation, as hemolysins 
are only expressed at high cell density and are turned 
off in scattered growing cells [46].
Conclusions
IE is an exquisite model of bacteria–host interactions. At 
ﬁrst glance, it is seems simple. Microbes equipped with 
speciﬁc adhesins can stick to pre-existing endovascular 
thrombi, in which they get embedded and are protected 
from host defenses. However, digging into these mecha-
nisms indicates that the microbes are equipped with an 
array of determinants that do not only attach to extra-
cellular matrix molecules but also directly to endothelia 
and platelets, which become activated and promote veg-
etation formation and growth. These interactions involve 
serial reactions with host components, including ﬁbrino-
gen, ﬁbronectin, von Willebrand factor, complement, and 
antibodies in the case of platelet activation. Bacteria can 
also invade endothelial cells, where they can either reside, 
thus evading host defenses and antibiotics, or escape to 
spread further after having lysed the host cell. Surviving 
the intracellular and extracellular milieus requires tight 
regulation of an array of pathogenic genes that are aimed 
at speciﬁc environmental-dependent tasks. 
On the side of the host, monocytes, endothelial cells, 
and platelets coordinately reunify both healing and 
antimicrobial processes. It is likely that these reactions 
successfully abort numerous episodes of bacteremia and 
early valve colonization. This could explain the inoculum 
dependency of IE, where a threshold number of bacteria 
is required for successful infection. However, these heal-
ing and defense systems can also become subverted by 
the bacteria.
Current interventions against IE primarily target 
the microbes. Although this is sound, knowing the host 
players that are subverted might help identify parallel 
targets of the host components. These have the advantage 
of being conserved, as opposed to microbial factors that 
vary depending on the infecting organisms. They will 
include modulating inﬂammation, expression of intercel-
lular adhesion molecules, and platelet functions.
Acknowledgments
This work was supported by grants #3200-65371.01 and 
3200-65371/2 from the Swiss National Fund for Scientiﬁc 
Research, and a grant from the Helmut Horten Founda-
tion to E. Widmer.
References and Recommended Reading
Papers of particular interest, published recently,  
have been highlighted as:
• Of importance
•• Of major importance
1. Moreillon P, Que YA: Infective endocarditis. Lancet 2004, 
363:139–149.
2. Bouza E, Menasalvas A, Munoz P, et al.: Infective endo-
carditis—a prospective study at the end of the twentieth 
century: new predisposing conditions, new etiologic 
agents, and still a high mortality. Medicine (Baltimore) 
2001, 80:298–307.
3. Abbott KC, Agodoa LY: Hospitalizations for bacterial 
endocarditis after initiation of chronic dialysis in the 
United States. Nephron 2002, 91:203–209.
4. Croft LB, Donnino R, Shapiro R, et al.: Age-related 
prevalence of cardiac valvular abnormalities warranting 
infectious endocarditis prophylaxis. Am J Cardiol 2004, 
94:386–389.
5. Camerer E, Kolsto AB, Prydz H: Cell biology of tissue fac-
tor, the principal initiator of blood coagulation. Thromb 
Res 1996, 81:1–41.
6. Yeaman MR: The role of platelets in antimicrobial host 
defense. Clin Infect Dis 1997, 25:951–968.
7. Veltrop MH, Beekhuizen H, Thompson J: Bacterial spe-
cies- and strain-dependent induction of tissue factor 
in human vascular endothelial cells. Infect Immun 1999, 
67:6130–6138.
8. Bancsi MJ, Veltrop MH, Bertina RM, et al.: Role of 
monocytes and bacteria in Staphylococcus epidermidis 
endocarditis. Infect Immun 1998, 66:448–450.
9. Bancsi MJ, Thompson J, Bertina RM: Stimulation of 
monocyte tissue factor expression in an in vitro model of 
bacterial endocarditis. Infect Immun 1994, 62:5669–5672.
10. Veltrop MH, Thompson J, Beekhuizen H: Monocytes aug-
ment bacterial species- and strain-dependent induction 
of tissue factor activity in bacterium-infected human vas-
cular endothelial cells. Infect Immun 2001, 69:2797–2807.
11.•• Dankert J, van der Werff J, Joldersma W, et al.: Interleukin 
1alpha increases the susceptibility of rabbits to experi-
mental viridans streptococcal endocarditis. Infect Immun 
2006, 74:947–952.
Describes the potential of circulating interleukin-1α for triggering 
inﬂammation of minimally altered valve endothelia, thus making 
them susceptible to bacterial colonization.
278 Cardiovascular Infections
12. Erickson PR, Herzberg MC: The Streptococcus sanguis 
platelet aggregation-associated protein. Identiﬁcation 
and characterization of the minimal platelet-interactive 
domain. J Biol Chem 1993, 268:1646–1649.
13. Manning JE, Hume EB, Hunter N, et al.: An appraisal 
of the virulence factors associated with streptococcal 
endocarditis. J Med Microbiol 1994, 40:110–114.
14. Moreillon P, Que YA, Bayer AS: Pathogenesis of strepto-
coccal and staphylococcal endocarditis. Infect Dis Clin 
North Am 2002, 16:297–318.
15. Bensing BA, Siboo IR, Sullam PM: Proteins PblA and PblB 
of Streptococcus mitis, which promote binding to human 
platelets, are encoded within a lysogenic bacteriophage. 
Infect Immun 2001, 69:6186–6192.
16. Fitzgerald JR, Loughman A, Keane F, et al.: Fibronectin-
binding proteins of Staphylococcus aureus mediate 
activation of human platelets via ﬁbrinogen and ﬁbronec-
tin bridges to integrin GPIIb/IIIa and IgG binding to the 
FcgammaRIIa receptor. Mol Microbiol 2006, 59:212–230.
17. Loughman A, Fitzgerald JR, Brennan MP, et al.: Roles for 
ﬁbrinogen, immunoglobulin and complement in platelet 
activation promoted by Staphylococcus aureus clumping 
factor A. Mol Microbiol 2005, 57:804–818.
18. Siboo IR, Chambers HF, Sullam PM: Role of SraP, a serine-
rich surface protein of Staphylococcus aureus, in binding 
to human platelets. Infect Immun 2005, 73:2273–2280.
19. Bayer AS, Sullam PM, Ramos M, et al.: Staphylococcus 
aureus induces platelet aggregation via a ﬁbrinogen-
dependent mechanism which is independent of principal 
platelet glycoprotein IIb/IIIa ﬁbrinogen-binding 
domains. Infect Immun 1995, 63:3634–3641.
20. Sullam PM, Bayer AS, Foss WM, et al.: Diminished platelet 
binding in vitro by Staphylococcus aureus is associated 
with reduced virulence in a rabbit model of infective 
endocarditis. Infect Immun 1996, 64:4915–4921.
21. Sullam PM, Frank U, Yeaman MR, et al.: Effect of 
thrombocytopenia on the early course of streptococcal 
endocarditis. J Infect Dis 1993, 168:910–914.
22. Dankert J, Van den Werff J, Zaat SAJ, et al.: Involvement of 
bactericidal factors from thrombin-stimulated platelets in 
clearance of adherent viridans streptococci in experimen-
tal infective endocarditis. Infect Immun 1995, 63:663–671.
23. Koo SP, Bayer AS, Kagan BL, et al.: Membrane permea-
bilization by thrombin-induced platelet microbicidal 
protein 1 is modulated by transmembrane voltage polar-
ity and magnitude. Infect Immun 1999, 67:2475–2481.
24. Weidenmaier C, Peschel A, Kempf VA, et al.: DltABCD- and 
MprF-mediated cell envelope modiﬁcations of Staphylo-
coccus aureus confer resistance to platelet microbicidal 
proteins and contribute to virulence in a rabbit endocar-
ditis model. Infect Immun 2005, 73:8033–8038.
25. Fowler VG Jr, McIntyre LM, Yeaman MR, et al.: In vitro 
resistance to thrombin-induced platelet microbicidal 
protein in isolates of Staphylococcus aureus from endo-
carditis patients correlates with an intravascular device 
source. J Infect Dis 2000, 182:1251–1254.
26. Taha TH, Durrant SS, Mazeika PK, et al.: Aspirin to prevent 
growth of vegetations and cerebral emboli in infective 
endocarditis. J Intern Med 1992, 231:543–546.
27. Nicolau DP, Tessier PR, Nightingale CH: Beneﬁcial effect 
of combination antiplatelet therapy on the development 
of experimental Staphylococcus aureus endocarditis. Int 
J Antimicrob Agents 1999, 11:159–161.
28. Kupferwasser LI, Yeaman MR, Nast CC, et al.: Salicylic 
acid attenuates virulence in endovascular infections by 
targeting global regulatory pathways in Staphylococcus 
aureus. J Clin Invest 2003, 112:222–233.
29. Tornos P, Almirante B, Mirabet S, et al.: Infective endocar-
ditis due to Staphylococcus aureus: deleterious effect of 
anticoagulant therapy. Arch Intern Med 1999, 159:473–475.
30. Mc Entergart MG, Porterﬁeld JS: Bacteremia following 
dental extraction. Lancet 1949, 2:596–598.
31. Hall G, Heimdahl A, Nord CE: Bacteremia after oral surgery 
and antibiotic prophylaxis for endocarditis. Clin Infect Dis 
1999, 29:1–8; quiz 9–10.
32. Bahn SL, Goveia G, Bitterman P, et al.: Experimental endocar-
ditis induced by dental manipulation and oral streptococci. 
Oral Surg Oral Med Oral Pathol 1978, 45:549–559.
33. Patti JM, Allen BL, McGavin MJ, et al.: MSCRAMM-medi-
ated adherence of microorganisms to host tissues. Annu 
Rev Microbiol 1994, 48:585–617.
34. Shun CT, Lu SY, Yeh CY, et al.: Glucosyltransferases of 
viridans streptococci are modulins of interleukin-6 
induction in infective endocarditis. Infect Immun 2005, 
73:3261–3270.
35. Viscount HB, Munro CL, Burnette-Curley D, et al.: 
Immunization with FimA protects against Streptococ-
cus parasanguis endocarditis in rats. Infect Immun 1997, 
65:994–1002.
36. Navarre WW, Schneewind O: Surface proteins of gram-
positive bacteria and mechanisms of their targeting 
to the cell wall envelope. Microbiol Mol Biol Rev 1999, 
63:174–229.
37. Palma M, Haggar A, Flock JI: Adherence of Staphylococ-
cus aureus is enhanced by an endogenous secreted 
protein with broad binding activity. J Bacteriol 1999, 
181:2840–2845.
38. Heilmann C, Hartleib J, Hussain MS, et al.: The multifunc-
tional Staphylococcus aureus autolysin aaa mediates 
adherence to immobilized ﬁbrinogen and ﬁbronectin. 
Infect Immun 2005, 73:4793–4802.
39. Weidenmaier C, Peschel A, Xiong YQ, et al.: Lack of wall 
teichoic acids in Staphylococcus aureus leads to reduced 
interactions with endothelial cells and to attenuated 
virulence in a rabbit model of endocarditis. J Infect Dis 
2005, 191:1771–1777.
40.•• Que YA, Haeﬂiger JA, Piroth L, et al.: Fibrinogen and 
ﬁbronectin binding cooperate for valve infection and 
invasion in Staphylococcus aureus experimental endo-
carditis. J Exp Med 2005, 201:1627–1635.
Discloses the critical molecular cooperation between S. aureus 
surface proteins binding to ﬁbrinogen and ﬁbronectin for valve 
colonization and endothelial invasion. 
41. Roche FM, Downer R, Keane F, et al.: The N-terminal 
A domain of ﬁbronectin-binding proteins A and B 
promotes adhesion of Staphylococcus aureus to elastin. 
J Biol Chem 2004, 279:38433–38440.
42. Massey RC, Kantzanou MN, Fowler T, et al.: Fibronectin-
binding protein A of Staphylococcus aureus has multiple, 
substituting, binding regions that mediate adherence 
to ﬁbronectin and invasion of endothelial cells. Cell 
Microbiol 2001, 3:839–851.
43. Wann E, Gurusiddappa S, Höök M: The ﬁbronectin-bind-
ing MSRAMM FnbpA of Staphylococcus aureus is a 
bifunctional protein that also binds to ﬁbrinogen. J Biol 
Chem 2000, 275:13863–13871.
44. Roche FM, Massey R, Peacock SJ, et al.: Characterization 
of novel LPXTG-containing proteins of Staphylococcus 
aureus identiﬁed from genome sequences. Microbiology 
2003, 149(Pt 3):643–654.
45. Massey R, Dissanayeke S, Cameron B, et al.: Functional 
blocking of Staphylococcus aureus adhesins following 
growth in ex vivo media. Infect Immun 2002, 70:5339–5345.
46. Cheung AL, Projan SJ, Gresham H: The genomic aspect 
of virulence, sepsis, and resistance to killing mecha-
nisms in Staphylococcus aureus. Curr Infect Dis Rep 
2002, 4:400–410.
47. Cheung AL, Eberhardt KJ, Chung E, et al.: Diminished 
virulence of a sar-/agr- mutant of Staphylococcus aureus 
in the rabbit model of endocarditis. J Clin Invest 1994, 
94:1815–1822.
48. Mayville P, Ji G, Beavis R, et al.: Structure-activity analysis of 
synthetic autoinducing thiolactone peptides from Staphylo-
coccus aureus responsible for virulence. Proc Natl Acad Sci U 
S A 1999, 96:1218–1223.
New Concepts in the Pathophysiology of Infective Endocarditis Widmer et al. 279
49. Entenza JM, Moreillon P, Senn MM, et al.: Role of sigmaB 
in the expression of Staphylococcus aureus cell wall 
adhesins ClfA and FnbA and contribution to infectivity 
in a rat model of experimental endocarditis. Infect Immun 
2005, 73:990–998.
50. Bayer AS, Ramos MD, Menzies BE, et al.: Hyperproduc-
tion of alpha-toxin by Staphylococcus aureus results 
in paradoxically reduced virulence in experimental 
endocarditis: a host defense role for platelet microbicidal 
proteins. Infect Immun 1997, 65:4652–4660.
